Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT

BlackRock, Inc. reported a 7.80% stake in Sagimet Biosciences Inc. - Series A (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 30, 2026

BlackRock, Inc. reported a 7.80% stake in Sagimet Biosciences Inc. - Series A, 4,751,186 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G).

Stake
7.80%
Shares
4,751,186
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.7.80%4,751,186

Source

View original at SEC

Related